Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Norvir Returns To Market Via Contract Manufacturer

Executive Summary

Abbott's HIV protease inhibitor Norvir capsules will be available the week of July 5 as a soft gelatin reformulation outsourced to a contract manufacturer.

You may also be interested in...



Abbott Diagnostics Manufacturing Issues Could Decrease Alza Merger Value

Abbott's pending merger with Alza could give FDA leverage in discussions over quality control problems in Abbott's diagnostics business.

Abbott Diagnostics Manufacturing Issues Could Decrease Alza Merger Value

Abbott's pending merger with Alza could give FDA leverage in discussions over quality control problems in Abbott's diagnostics business.

Abbott Expects Prevacid Growth Of 25% Despite Looming PPI Competition

Abbott is expecting 25% U.S. growth for TAP's Prevacid next year, despite potential competition from two new proton pump inhibitors.

Related Content

UsernamePublicRestriction

Register

PS034420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel